Update on the Protective Renal Effects of Metformin in Diabetic Nephropathy

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|24|31|3397-3412

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.24, Iss.31, 2017-10, pp. : 3397-3412

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Renal protective effect of YM598, a selective endothelin ET A receptor antagonist, against diabetic nephropathy in OLETF rats

By Sugimoto K.-i.   Tsuruoka S.   Fujimura A.  

European Journal of Pharmacology, Vol. 450, Iss. 2, 2002-08 ,pp. : 183-189

Elsevier

Access to resources Recommend Favorite

Suppressing renal NADPH oxidase to treat diabetic nephropathy

By Tojo Akihiro   Asaba Kensuke   Onozato Maristela L  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 8, 2007-08 ,pp. : 1011-1018

Informa Healthcare

Access to resources Recommend Favorite

Vasoactive Renal Factors and the Progression of Diabetic Nephropathy

By  

Current Pharmaceutical Design, Vol. 10, Iss. 27, 2004-10 ,pp. : 3373-3384

Bentham Science Publishers

Access to resources Recommend Favorite

An update of irbesartan and renin-angiotensin system blockade in diabetic nephropathy

By García-Donaire Jose Antonio   Segura Julian   Ruilope Luis Miguel  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 9, 2005-08 ,pp. : 1587-1596

Informa Healthcare

Access to resources Recommend Favorite

Diabetic nephropathy

By Wylie Emma C   Satchell Simon C  

Clinical Medicine, Vol. 12, Iss. 5, 2012-10 ,pp. : 480-482

Royal College Of Physicians

Access to resources Recommend Favorite